(Q56384880)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19026180%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Current management of hypertrophic cardiomyopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19026180%20AND%20SRC:MED&resulttype=core&format=json

hypertrophic cardiomyopathy

17 January 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19026180%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Perry M Elliott

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19026180%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19026180%20AND%20SRC:MED&resulttype=core&format=json

Current treatment options in cardiovascular medicine

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19026180%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19026180%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19026180%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

496-504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19026180%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11936-008-0042-9

17 January 2020

exact match

0 references

cites work

Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1007%2FS11936-008-0042-9

Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-008-0042-9

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-008-0042-9

Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-008-0042-9

Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-008-0042-9

Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11936-008-0042-9

Hypertrophic cardiomyopathy

21 January 2018

1 reference

12 December 2020

Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.

1 reference

12 December 2020

Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Resynchronization or Dyssynchronization?Successful Treatment with Biventricular Stimulation of a Child with Obstructive Hypertrophic Cardiomyopathy without Dyssynchrony

1 reference

12 December 2020

Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy

1 reference

12 December 2020

1 reference

12 December 2020

Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis

1 reference

12 December 2020

Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing.

1 reference

12 December 2020

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

1 reference

12 December 2020

Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitati

1 reference

12 December 2020

Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy

1 reference

12 December 2020

Dual chamber pacing in hypertrophic obstructive cardiomyopathy: beneficial effect of atrioventricular junction ablation for optimal left ventricular capture and filling

1 reference

12 December 2020

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European S

1 reference

12 December 2020

Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy

1 reference

12 December 2020

Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy

1 reference

12 December 2020

Sudden Death in Hypertrophic Cardiomyopathy

1 reference

12 December 2020

Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy

1 reference

12 December 2020

A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment

1 reference

12 December 2020

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro

1 reference

12 December 2020

Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia

1 reference

12 December 2020

Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy

1 reference

12 December 2020

Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction

1 reference

12 December 2020

Hypertrophic cardiomyopathy: a systematic review

1 reference

12 December 2020

Disease-Modifying Mutations in Familial Hypertrophic Cardiomyopathy

1 reference

12 December 2020

1 reference

12 December 2020

Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy

1 reference

12 December 2020

Effect of Losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy

1 reference

12 December 2020

Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients

1 reference

12 December 2020

Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.

1 reference

12 December 2020

EFFECTS OF BETA ADRENERGIC BLOCKADE ON THE CIRCULATION WITH PARTICULAR REFERENCE TO OBSERVATIONS IN PATIENTS WITH HYPERTROPHIC SUBAORTIC STENOSIS

1 reference

12 December 2020

Implications of left ventricular remodeling in hypertrophic cardiomyopathy

1 reference

12 December 2020

Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group

1 reference

12 December 2020

Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group

1 reference

12 December 2020

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

1 reference

12 December 2020

Effect of biventricular pacing on symptoms and cardiac remodelling in patients with end-stage hypertrophic cardiomyopathy

1 reference

12 December 2020

Risk associated with pregnancy in hypertrophic cardiomyopathy

1 reference

12 December 2020

Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Phenotypic diversity in hypertrophic cardiomyopathy

1 reference

12 December 2020

Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy

1 reference

12 December 2020

Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?

1 reference

12 December 2020

Heart transplantation in hypertrophic cardiomyopathy

1 reference

12 December 2020

Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and marfan syndrome : A statement for healthcare professionals from the

1 reference

12 December 2020

Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration

1 reference

12 December 2020

Perioperative anesthetic risk of noncardiac surgery in hypertrophic obstructive cardiomyopathy.

1 reference

12 December 2020

Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy

1 reference

12 December 2020

Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression

1 reference

12 December 2020

Usefulness and Safety of Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy

1 reference

12 December 2020

10.1007/S11936-008-0042-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19026180%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference